case_images: PMC5816871_01
case_images: Peripheral smear showing frequent elliptocytes, tear drop cells, schistocytes, and occasional spherocytes.
case_images: CRIHEM2018-6819172.001.jpg
case_images: PMC5816871_01_CRIHEM2018-6819172.001.jpg
case_images: fig1
case_images: Peripheral smear in Figure 1 shows frequent elliptocytes, teardrop cells, schistocytes, and occasional spherocytes.
case_images: A bone marrow aspirate (a) and core biopsy (b) showing a hypercellular marrow with trilineage dyspoiesis and associated erythroid hyperplasia without any fibrosis.
case_images: CRIHEM2018-6819172.002.jpg
case_images: PMC5816871_01_CRIHEM2018-6819172.002.jpg
case_images: fig2
case_images: A bone marrow aspirate and core biopsy in Figure 2 show a hypercellular marrow with trilineage dyspoiesis and associated erythroid hyperplasia without any fibrosis.
case_images: Iron staining before treatment showing increased storage and sideroblastic iron with few ring sideroblastic iron.
case_images: CRIHEM2018-6819172.003.jpg
case_images: PMC5816871_01_CRIHEM2018-6819172.003.jpg
case_images: fig3
case_images: Peripheral smear showing improvement in elliptocytosis after completion of 6 cycles of treatment with azacytidine.
case_images: CRIHEM2018-6819172.004.jpg
case_images: PMC5816871_01_CRIHEM2018-6819172.004.jpg
case_images: fig4
case_images: Patient has been independent of any supportive transfusions, and repeat bone marrow biopsy after completion of 6 cycles showed complete cytogenetic remission as well as significant improvement in elliptocytosis as shown in Figure 4.